Elephas
Steven Galson, MD, MPH, currently serves as a Board Member at BioCryst Pharmaceuticals, Inc. and Elephas, and as a Senior Advisor at the Boston Consulting Group. From September 2010 to June 2021, Steven held multiple senior vice president roles at Amgen, overseeing research and development as well as global regulatory affairs and strategy. Previous experience includes membership on the board of directors at Vanda Pharmaceuticals and a senior vice president role at Leidos, managing civilian health operations. Steven also served as the Acting Assistant Secretary for Health at the U.S. Department of Health and Human Services and held the position of Acting Surgeon General at the FDA. Academic credentials include an MD from the Icahn School of Medicine at Mount Sinai, an MPH from Harvard T.H. Chan School of Public Health, and a BS in Biochemistry from Stony Brook University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Elephas
Disruption in healthcare is accelerated by the need for improved diagnostics, novel pharmaceutical therapies, and the shift to patient-centric solutions. With the mission to tackle the massive oncology dilemma, Elephas is leading the way to change how clinicians treat cancer patients. By harnessing the latest advances in cancer biology, multimodalmicroscopy, and artificial intelligence, the Elephas platform has the ability to empower clinical decision-making and accelerate drug development.